Bo Peng

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia

Adriana E. Tron, Matthew A. Belmonte, Ammar Adam et al. · Nature Communications · 2018 · 486 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer

Jianming Xu, Haiping Jiang, Yueyin Pan et al. · JAMA · 2023 · 357 citations · Full text

Medicine, Oncology, Pharmacology +17

Systemic immune-inflammation index and bone mineral density in postmenopausal women: A cross-sectional study of the national health and nutrition examination survey (NHANES) 2007-2018

Yuchen Tang, Bo Peng, Jinmin Liu et al. · Frontiers in Immunology · 2022 · 188 citations · Full text

Medicine, Nutrition, Nutritional Sciences +17

Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit

Jie Wang, Keke Fei, Jing Hua et al. · mAbs · 2019 · 156 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Tumour evolution and microenvironment interactions in 2D and 3D space

Chia-Kuei Mo, Jingxian Liu, Siqi Chen et al. · Nature · 2024 · 151 citations · Full text

Medicine, Cancer Biology, Oncology +16